Burns and metabolism

Journal of the American College of Surgeons

Volumn 188, Issue 2, 1999, Pages 98-103

  Hasselgren, Per Olof ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUTAMINE; GROWTH HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR;

BURN; CACHEXIA; METABOLISM; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; REVIEW; SEPSIS; SIGNAL TRANSDUCTION;

EID: 0032939207     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00297-X     Document Type: Article

References (49)

1. Hill AG, Hill GL. Metabolic response to severe injury. Br J Surg 1998;85:884-890.
2. Katz JA, Lowry SF. Substrate utilization in hypermetabolism. In: Fein AM, Abraham E, Balk R, et al, eds. Sepsis and Multiorgan Failure. Philadelphia: Williams & Williams, 1998:96-106.
3. Chang HR, Bistrian B. The role of cytokines in the catabolic consequences of infection and injury. J Parent Ent Nutr 1998;22:156-166.
4. Price SR, Mitch WE. Mechanisms stimulating protein degradation to cause muscle atrophy. Curr Opin Clin Nutr Metab Care 1998;1:79-83.
5. Fang CH, Wang JJ, Hobler S, et al. Proteasome blockers inhibit protein breakdown in skeletal muscle after burn injury in rats. Clin Sci 1998;95:225-233.
6. Hobler S, Tiao G, Fischer JE, et al. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. Am J Physiol 1998;274:R30-R37.
7. 2+-dependent release of myofilaments increases in skeletal muscle during sepsis. Surg Forum 1998;49:66-69.
8. Argiles JM, López-Soriano FJ. Catabolic proinflammatory cytokines. Curr Opin Clin Nutr Metab Care 1998;1:245-251.
9. Baraccos VE. Anabolic and catabolic mediators. Curr Opin Nutr Metab Care 1998;1:241-244.
10. Williams A, Wang JJ, Wang L, et al. Sepsis in mice stimulates muscle proteolysis in the absence of IL-6. Am J Physiol 1998; 275:in press.
11. Tisdale MJ. New cachexie factors. Curr Opin Clin Nutr Metab Care 1998;1:253-256.
12. Rivadeneira DE, Grobmyer SR, Naama HA, et al. Protein-calorie malnutrition increases apoptosis in peritoneal macrophages. Surg Forum 1998;49:62-64.
13. Barry L, Mestre J, McCarter M, et al. Protein calorie malnutrition attenuates NF-κB activation in peritoneal macrophages. Surg Forum 1998;49:117-119.
14. Sheridan RL, Yu YM, Prelack K, et al. Maximal parenteral glucose oxidation in hypermetabolic young children. A stable isotope study. J Parent Ent Nutr 1998;22:212-216.
15. Tashiro T, Yamamori H, Takagi K, et al. n - 3 versus n - 6 polyunsaturated fatty acids in critical illness. Nutrition 1998;14:551-553.
16. Druml W, Fischer M, Ratheiser K. Use of intravenous lipids in critically ill patients with sepsis without and with hepatic failure. J Parent Ent Nutr 1998;22:217-223.
17. Demling RH, DeSanti L. Increased protein intake during the recovery phase after severe burns increases body weight gain and muscle function. J Burn Care Rehabil 1998;19:161-168.
18. Windsor ACJ, Kanwar S, Li AGK, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute phase response and improves disease severity in acute pancreatitis. Gut 1998;42:431-435.
19. Kiyama T, Witte MB, Thornton FJ, Barbul A. The route of nutrition support affects the early phase of wound healing. J Parent Ent Nutr 1998;22:276-279.
20. Evoy D, Lieberman MD, Fahey TJ, Daly JM. Immunonutrition: The role of arginine. Nutrition 1998;14:611-617.
21. Wilmore DW, Shabert JK. Role of glutamine in immunologic responses. Nutrition 1998;14:618-626.
22. Alexander JW. Immunonutrition: The role of ω-3 fatty acids. Nutrition 1998;14:627-633.
23. Bengmark S. Immunonutrition: Role of biosurfactants, fiber, and probiotic bacteria. Nutrition 1998;14:585-594.
24. Lipman TO. Grains or veins: Is enterai nutrition really better than parenteral nutrition? A look at the evidence. J Parent Ent Nutr 1998;22:167-182.
25. Schröder J, Kahlke V, Fändrich F, et al. Glutamine dipeptides-supplemented parenteral nutrition reverses gut mucosal structure and interleukin-6 release of rat intestinal mononuclear cells after hemorrhagic shock. Shock 1998;10:26-31.
26. Cao Y, Feng Z, Hoos A, Klimberg VS. Glutamine enhances gut glutathione production. J Parent Ent Nutr 1998;22:224-227.
27. DeBeaux AC, O'Riordain MG, Ross JA, et al. Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition 1998;14:261-265.
28. Rennie MJ. Nutritional and pathophysiological modulation of body protein. Curr Opin Clin Nutr Metab Care 1998;1:67-71.
29. McCauley R, Kong SE, Hall J. Glutamine and nucleotide metabolism within enterocytes. J Parent Ent Nutr 1998;22:105-111.
30. Fang CH, Li BG, Wang JJ, et al. Insulin-like growth factor I (IGF-I) stimulates protein synthesis and inhibits protein breakdown in muscle from burned rats. J Parent Ent Nutr 1997;21:245-251.
31. Fang CH, Li BG, Wang JJ, et al. Treatment of burned rats with insulin-like growth factor I inhibits the catabolic response in skeletal muscle. Am J Physiol 1998;275:R1091-R1098.
32. Fang CH, Li BG, James JH, et al. The anabolic effects of IGF-I in skeletal muscle after burn injury are not caused by increased cell volume. J Parent Ent Nutr 1998;22:115-119.
33. Hobler SC, Williams AB, Fischer JE, Hasseigren PO. IGF-I stimulates protein synthesis but does not inhibit protein breakdown in muscle from septic rats. Am J Physiol 1998;274:R571-R576.
34. Bettany GEA, Camacho-Hubner C, Obeid O, et al. Metabolic effects of adjuvant recombinant human growth hormone in patients with continuing sepsis receiving parenteral nutrition. J Parent Ent Nutr 1998;22:199-205.
35. Wingertzahn MA, Zdanowicz MM, Slonim AE. Insulin-like growth factor-I and high protein diet decrease calpain-mediated proteolysis in murine muscular dystrophy. PSEBM 1998;218: 244-250.
36. DebRoy MA, Zhang XJ, Wolf SE, et al. Anabolic effects of administration of recombinant human insulin-like growth factor I/binding protein 3 on protein metabolism in adult burn patients. Surg Forum 1998;49:56-57.
37. Welle S. Growth hormone and insulin-like growth factor-I as anabolic agents. Curr Opin Clin Nutr Metab Care 1998;1:257-262.
38. Dahn MS, Lange MP. Systemic and splanchnic metabolic response to exogenous human growth hormone. Surgery 1998;123: 528-533.
39. Bjarnason R, Wickelgren R, Hermanson M, et al. Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery. J Clin Endocrinol Metab 1998;83:1566-1572.
40. Public communication from Pharmacia & Upjohn Pharmaceuticals and Rolf Gunnarson, MD to all industry and medical community involved with the use or potential use of recombinant human growth hormone, Oct. 1997.
41. Ramirez RJ, Wolf SE, Barrow AE, Herndon DN. Growth hormone treatment in pediatric burns. A safe therapeutic approach. Ann Surg 1998;228:439-448.
42. Kumwenda ZL, Welch WJ, Harris HW. Chylomicron-bound endotoxin inhibits hepatocellular nitric oxide production by inhibiting nuclear factor κB activation in rats. Surg Forum 1998;49:8-9.
43. Unno N, Nakamura S, Baba S, et al. Lipopolysaccharide-induced inducible nitric oxide synthase gene expression is downregulated in rats rendered tolerant to endotoxin, possibly as a result of enhanced glucocorticoid release. Surg Forum 1998;49:10-11.
44. Hierholzer C, Menezes J, Kalff JC, et al. Essential role of induced nitric oxide in intestinal inflammation and stasis following hemorrhagic shock. Surg Forum 1998;49:78-80.
45. Villavicencio RT, Pitt BR, Gauster R, et al. Inducible nitric oxide synthase inhibits activation of NF-κB and STAT3. Surg Forum 1998;49:115-116.
46. Moon MR, Parikh AA, Pritts TA, et al. Complement component C3 production in IL-1β-stimulated human intestinal epithelial cells is blocked by NF-κB inhibitors and by transfection with Ser 32/36 mutant IκBα. J Surg Res 1998;in press.
47. Parikh AA, Moon MR, Fischer JE, et al. Heat shock inhibits activation of the inflammatory transcription factor NF-κB in human intestinal epithelial cells. Surg Forum 1998;49:112-114.
48. Josephs MD, Taylor MW, Rosenberg JJ, et al. Identifying a role for endogenous interleukin-1 receptor antagonist in the inflammatory response to a turpentine abscess. Surg Forum 1998;49:74-76.
49. Peflegrin K, Peterson VM, Ketch LL. Administration of interleukin 1 receptor antagonist, an anti-inflammatory, counter-regulatory cytokine, promotes bone marrow failure after burn injury. Surg Forum 1998;49:610-612.